Ignite Creation Date:
2024-05-05 @ 11:37 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00097513
Status:
COMPLETED
Last Update Posted:
2010-11-15
First Post:
2004-11-24
Brief Title:
National Cooperative Growth Study NCGS of Optimal Nutropin AQ and Nutropin Dosing in Pubertal Growth Hormone-Deficient GHD Patients
Sponsor:
Genentech Inc
Organization:
Genentech Inc
Study Overview
Official Title:
National Cooperative Growth Study NCGS of Optimal Nutropin AQ and Nutropin Dosing in Pubertal Growth Hormone-Deficient GHD Subjects
Status:
COMPLETED
Status Verified Date:
2010-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is a multicenter open-label observational postmarketing surveillance study that will collect information on the use of Genentech GH preparations to treat GH-deficient subjects with optimal GH dosing during puberty
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None